These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Two-year observation of a randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplantation. Zhu QG, Zhao YK, Liu W, Luo H, Qiu Y, Gao ZZ. Chin Med Sci J; 2008 Dec; 23(4):244-8. PubMed ID: 19180887 [Abstract] [Full Text] [Related]
14. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. Stegall MD, Wachs ME, Everson G, Steinberg T, Bilir B, Shrestha R, Karrer F, Kam I. Transplantation; 1997 Dec 27; 64(12):1755-60. PubMed ID: 9422416 [Abstract] [Full Text] [Related]
15. Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens. Wlodarczyk Z, Walaszewski J, Perner F, Vitko S, Ostrowski M, Bachleda P, Kokot F, Klinger M, Szenohradszky P, Studenik P, Navratil P, Asztalos L, Rutkowski B, Kalmar KN, Hickey D. Transpl Int; 2005 Feb 27; 18(2):157-62. PubMed ID: 15691267 [Abstract] [Full Text] [Related]
16. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient. Montini G, Murer L, Ghio L, Pietrobon B, Ginevri F, Ferraresso M, Cardillo M, Scalamogna M, Perfumo F, Edefonti A, Zanon GF, Zacchello G. Transpl Int; 2005 Jan 27; 18(1):36-42. PubMed ID: 15612981 [Abstract] [Full Text] [Related]
17. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study. Abramowicz D, Del Carmen Rial M, Vitko S, del Castillo D, Manas D, Lao M, Gafner N, Wijngaard P, Cyclosporine Withdrawal Study Group. J Am Soc Nephrol; 2005 Jul 27; 16(7):2234-40. PubMed ID: 15917338 [Abstract] [Full Text] [Related]
18. Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up. Lee YJ, Kim B, Lee JE, Kim YG, Kim DJ, Kim SJ, Joh JW, Oh HY, Huh W. Transpl Int; 2010 Feb 27; 23(2):147-54. PubMed ID: 19744223 [Abstract] [Full Text] [Related]
19. Cost-benefit of steroid avoidance in renal transplant patients: a prospective randomized study. Gheith OA, Nematalla AH, Bakr MA, Refaie A, Shokeir AA, Ghoneim MA. Scand J Urol Nephrol; 2010 Apr 27; 44(3):175-82. PubMed ID: 20230185 [Abstract] [Full Text] [Related]
20. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation. Triemer HL, Pearson TC, Odom KL, Larsen CP. Clin Transplant; 2000 Aug 27; 14(4 Pt 2):413-20. PubMed ID: 10946781 [Abstract] [Full Text] [Related] Page: [Next] [New Search]